Effective August 2, 2022, mdxhealth has acquired the Oncotype DX Genomic Prostate Score (GPS) test from Exact Sciences. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the press release.
Questions? Email: gps@mdxhealth.com

Genomic profiling: clarity on how to fight your tumor

Advanced. Metastatic. Refractory. Relapsed. Recurrent. Not exactly words you want to hear when it comes to your solid tumor cancer. But when you hear that your tumor tissue has been sent out for genomic profiling, you can feel good knowing that you’re getting useful information.

The Oncomap™ test is a genomic test that looks at hundreds of genes within your tumor to give you and your doctor personalized insights into which treatment options may be most appropriate to fight against your tumor.

If you have advanced-stage cancer, you can get fast, actionable insights into which treatments, immunotherapies, or clinical trials could be most appropriate, based on gene mutations of your tumor. Get an understanding of the testing process, learn what you can expect from the results, explore FAQs, and more.

92%
of Oncomap test patients have $0 financial responsibility*

This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid, and commercial insurance and includes the cost of both NGS and IHC components as most commonly ordered by providers. Patient cost-sharing amounts, including deductibles and copays, will vary by plan and coverage type. Only your insurance provider can confirm if and how the Oncomap test will be covered.

97%
of Oncomap test patients have a financial responsibility of <$100*

This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid, and commercial insurance and includes the cost of both NGS and IHC components as most commonly ordered by providers. Patient cost-sharing amounts, including deductibles and copays, will vary by plan and coverage type. Only your insurance provider can confirm if and how the Oncomap test will be covered.

* The number cited is based on historical patient billing data from 1/2/2021 to 12/31/2021. Rates of coverage vary by state and region. Exceptions for coverage may apply. Exact Sciences strongly encourages patients to contact their insurer with questions about Oncomap test coverage.